DermTech Inc Equity-NMS: DMTK


Diagnostics & Research

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Previous close :$2.55
52W high :$8.93
1Y :-61.79%
5Y :-74.3%
Shares O/S :31.09 M
Market cap :77.57 M

Compare with Other Stocks

Frequently Asked Questions

What is the share price of DermTech Inc today?

DermTech Inc (DMTK) share price as of June 5, 2023, is $2.49. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of DermTech Inc?

Yes, Indian Investors can invest in the DermTech Inc (DMTK) Share by opening an international trading account with Angel One.

How can I purchase DermTech Inc shares in India?

Purchasing DermTech Inc (DMTK) share from India can be done by:
  1. Directly: By opening an international trading account with Angel One. The process would include KYC verification.
    The account activation takes a few minutes to a few hours, after which you can start buying DermTech Inc (DMTK) by making deposits in US dollars.
  2. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of DermTech Inc?

Yes, you can purchase fractional shares of DermTech Inc (DMTK) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of DermTech Inc?

The market capitalization of DermTech Inc on June 5, 2023, is $77.57 M.

In which sector DermTech Inc belongs?

DermTech Inc operates in the Healthcare sector, specifically in the Diagnostics & Research industry.

What documents are required to invest in DermTech Inc stocks?

In order to invest in DermTech Inc (DMTK) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

About DermTech Inc

DermTech, Inc. is a molecular diagnostics company. The Company is focused on developing and marketing non-invasive genomics tests to aid in the diagnosis and management of skin cancer, inflammatory skin diseases, and aging-related skin conditions. Its technology enhances early melanoma detection by non-invasively detecting genomic markers associated with melanoma to identify higher risk lesions at their earliest stages to rule out melanoma. It provides genomic analysis of skin samples collected non-invasively using its Smart Stickers. Its DermTech Melanoma Test (the DMT) facilitates the clinical assessment of pigmented skin lesions that raise the concern for melanoma. Its commercial test addresses unmet needs in the diagnostic pathway of pigmented skin lesions, dark-colored patches of skin often referred to as moles. It markets the DMT under the name Pigmented Lesion Assay (PLA). It is also focuses on products to assess precancerous genomic changes associated with UV sun exposure.